Who Paid My Doc
Onyx 18
Device Liquid Embolics
PDI 00847536006171
General payments
$430,962
Research payments
$8,736,076
Through program year 2025, $430,962 in general payments and $8,736,076 in research payments were reported against Onyx 18 (Liquid Embolics).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $76,228 | 323 |
| 2025 | Research | $2,210,906 | 310 |
| 2024 | General | $182,359 | 238 |
| 2024 | Research | $1,049,556 | 229 |
| 2023 | General | $66,765 | 250 |
| 2023 | Research | $2,765,508 | 300 |
| 2022 | General | $105,610 | 580 |
| 2022 | Research | $2,710,105 | 295 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 19 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 35 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,391 general · 1,134 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.